Publicaciones en colaboración con investigadores/as de Mayo Clinic (38)

2024

  1. Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies

    Cancer Epidemiology Biomarkers and Prevention, Vol. 33, Núm. 3, pp. 389-399

2023

  1. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies

    The Lancet. Public health, Vol. 8, Núm. 9, pp. e691-e700

  2. Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions

    Journal of the National Cancer Institute, Vol. 115, Núm. 6, pp. 712-732

2022

  1. Accounting for EGFR Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

    Cancer Epidemiology Biomarkers and Prevention, Vol. 31, Núm. 3, pp. 679-687

  2. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86

  3. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry

    Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136

  4. Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis

    The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 4, pp. 243-252

  5. Clinical and Epidemiological Correlates of Low IFN-Gamma Responses in Mitogen Tube of QuantiFERON Assay in Tuberculosis Infection Screening During the COVID-19 Pandemic: A Population-Based Marker of COVID-19 Mortality?

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 649-659

  6. Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))

    Pharmacopsychiatry

2021

  1. A reply to “Lung cancer outcomes: Are BMI and race clinically relevant?”

    Lung Cancer

  2. New Research Strategies in Latent Tuberculosis Infection

    Archivos de Bronconeumologia

  3. The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients

    Lung Cancer, Vol. 152, pp. 58-65

2020

  1. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 3, pp. 323-331

  2. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

    International Journal of Cardiology, Vol. 299, pp. 49-55

  3. Genetic determinants of lung cancer prognosis in never smokers: A pooled analysis in the international lung cancer consortium

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 10, pp. 1983-1992

  4. Nuevas perspectivas en infección tuberculosa latente

    Archivos de bronconeumologia

2019

  1. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

    Nature Genetics

  2. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium

    Journal of Thoracic Oncology, Vol. 14, Núm. 9, pp. 1594-1607

  3. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics, Vol. 51, Núm. 3, pp. 414-430

  4. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region

    Journal of Thoracic Oncology, Vol. 14, Núm. 8, pp. 1360-1369